Moderna Messenger RNA Combo Shot Puts COVID And Flu ‘Vaccines’ Together In Terrifying New Injection That No Human Being Should Ever Consider Taking

06/11/2024

Moderna Messenger RNA Combo Shot Puts COVID And Flu ‘Vaccines’ Together In Terrifying New Injection That No Human Being Should Ever Consider Taking

EndTimesProphecyWatch.com

June 11, 2024

1–2 minutes

WE NEED YOUR SUPPORT: Our Christian Ministry / Website is 100% supported by our visitors. We do not sell products or place ads all across our website as we feel they are too intrusive. We want your experience on our website to be as pleasant as possible. It is because of loyal people like you that we can continue to bring the Gospel of Jesus Christ to our visitors and to continue to update our website, sounding the trumpet, with up-to-date prophetic news to people across the world! We need your support to continue to press forward with our ministry. Consider offering a donation of any size, as the Holy Spirit leads you. We thank you GREATLY for your tithes and offerings. CLICK HERE to make your donation today. God Bless You! Osvaldo Roldan, Founder – End Times Prophecy Watch

NEWS REPORT:

Moderna said its combination vaccine targeting Covid and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.
The biotech company is the first to release positive phase three data on a Covid and flu combination shot, giving it a potential lead over rivals Pfizer and Novavax.
Moderna plans to file for regulatory approval for its combination jab this summer in the U.S. and hopes it can enter the market in 2025, said the company’s CEO Stephane Bancel. Moderna on Monday said its combination vaccine that targets both Covid-19 and the flu was more effective than existing standalone shots for those viruses in a late-stage trial.
The biotech company is the first to release positive phase three data on a Covid and flu combination shot, giving it a potential lead over rival vaccine makers Pfizer and Novavax.
Moderna plans to file for regulatory approval for its combination jab this summer in the U.S. and hopes it can enter the market in 2025, the company’s CEO Stephane Bancel said in an interview.
Moderna, Pfizer and Novavax have said that combination shots will simplify how people can protect themselves against respiratory viruses that typically surge around the same time of the year. The added convenience is critical as fewer Americans roll up their sleeves to get vaccinated against Covid.
Bancel added that combination shots could reduce the burden of respiratory viruses on pharmacists and the broader U.S. health-care system, which has been grappling with a labor shortage that has many workers stretched thin.